Liu, A., Wildman-Tobriner, B., Strickler, J., Hsu, D., Thacker, J. K. M., Mantyh, C. R., … Lidsky, M. E. (2025). ctDNA as a novel biomarker of treatment efficacy in patients with unresectable colorectal liver metastases treated with hepatic arterial infusion. In ANNALS OF SURGICAL ONCOLOGY (Vol. 32, pp. S109–S109).

Liu, Annie, Benjamin Wildman-Tobriner, John Strickler, David Hsu, Julie K. M. Thacker, Christopher R. Mantyh, Billy Lan, et al. “ctDNA as a novel biomarker of treatment efficacy in patients with unresectable colorectal liver metastases treated with hepatic arterial infusion.” In ANNALS OF SURGICAL ONCOLOGY, 32:S109–S109, 2025.

Liu A, Wildman-Tobriner B, Strickler J, Hsu D, Thacker JKM, Mantyh CR, et al. ctDNA as a novel biomarker of treatment efficacy in patients with unresectable colorectal liver metastases treated with hepatic arterial infusion. In: ANNALS OF SURGICAL ONCOLOGY. 2025. p. S109–S109.

Liu, Annie, et al. “ctDNA as a novel biomarker of treatment efficacy in patients with unresectable colorectal liver metastases treated with hepatic arterial infusion.” ANNALS OF SURGICAL ONCOLOGY, vol. 32, 2025, pp. S109–S109.

Liu A, Wildman-Tobriner B, Strickler J, Hsu D, Thacker JKM, Mantyh CR, Lan B, Hill SS, Reason EH, Sullivan B, Nussbaum DP, Zani S, Allen PJ, Uronis H, Lidsky ME. ctDNA as a novel biomarker of treatment efficacy in patients with unresectable colorectal liver metastases treated with hepatic arterial infusion. ANNALS OF SURGICAL ONCOLOGY. 2025. p. S109–S109.